Skip to main content

Table 3 EZ-ALBI and ALBI score/grade at baseline and after TACE

From: Validation and prognostic value of EZ-ALBI score in patients with intermediate-stage hepatocellular carcinoma treated with trans-arterial chemoembolization

Scores and grade Baseline (N = 163)
N (%)/ mean ± SD
Post-TACE (N = 145)
N (%)/ mean ± SD
p-value
EZ-ALBI score − 37.70 ± 92.63 − 27.61 ± 5.51 0.185
EZ-ALBI grade
 -Grade 1
 -Grade 2
 -Grade 3
40 (24.5%)
114 (69.9%)
9 (5.5%)
16 (11.0%)
105 (72.4%)
24 (16.6%)
 
ALBI score − 2.89 ± 8.76 − 1.93 ± 0.59 0.181
ALBI-grade
 -Grade 1
 -Grade 2
 -Grade 3
40 (24.6%)
111 (68.0%)
12 (7.4%)
18 (12.4%)
95 (65.5%)
32 (22.1%)
 
  1. ALBI Albumin-bilirubin, EZ-ALBI Easy albumin-bilirubin, N Number, SD Standard deviation, TACE Trans-arterial chemoembolization